Mondrian Investment Partners LTD Novartis Ag Transaction History
Mondrian Investment Partners LTD
- $5.45 Billion
- Q3 2025
A detailed history of Mondrian Investment Partners LTD transactions in Novartis Ag stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 5,724 shares of NVS stock, worth $752,992. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,724
Previous 189,861
96.99%
Holding current value
$752,992
Previous $21.2 Million
96.53%
% of portfolio
0.01%
Previous 0.39%
Shares
23 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...